Outcomes of 13 women with 22 pregnancies following recovery from TTP
Woman . | Pregnancy . | Pregnancy outcome . | Child outcome . |
---|---|---|---|
1 | 1 | Normal | Normal |
2 | Normal | Normal | |
2 | 3 | 13 wk fetal loss | NA |
4 | 12 wk fetal loss | NA | |
3 | 5 | Normal | Normal |
6 | Normal | Normal | |
4 | 7 | Severe preeclampsia | Normal |
8 | Severe preeclampsia | Normal | |
5 | 9 | Normal | Normal |
10 | Normal | Normal | |
6 | 11 | Preeclampsia | Normal |
12 | Preeclampsia, TTP relapse 29 d postpartum | Normal | |
7 | 13 | Severe preeclampsia, TTP relapse 9 d postpartum | Normal |
8 | 14 | 20 wk fetal loss | NA |
15 | Normal | Normal | |
16 | Normal | Normal | |
9 | 17 | Normal | Normal |
10 | 18 | SLE flare | Normal |
11 | 19 | Normal | Normal |
20 | Normal | Normal | |
12 | 21 | Fetal growth retardation, delivery at 26 wk | Died, sepsis |
13 | 22 | Preeclampsia | Normal |
Woman . | Pregnancy . | Pregnancy outcome . | Child outcome . |
---|---|---|---|
1 | 1 | Normal | Normal |
2 | Normal | Normal | |
2 | 3 | 13 wk fetal loss | NA |
4 | 12 wk fetal loss | NA | |
3 | 5 | Normal | Normal |
6 | Normal | Normal | |
4 | 7 | Severe preeclampsia | Normal |
8 | Severe preeclampsia | Normal | |
5 | 9 | Normal | Normal |
10 | Normal | Normal | |
6 | 11 | Preeclampsia | Normal |
12 | Preeclampsia, TTP relapse 29 d postpartum | Normal | |
7 | 13 | Severe preeclampsia, TTP relapse 9 d postpartum | Normal |
8 | 14 | 20 wk fetal loss | NA |
15 | Normal | Normal | |
16 | Normal | Normal | |
9 | 17 | Normal | Normal |
10 | 18 | SLE flare | Normal |
11 | 19 | Normal | Normal |
20 | Normal | Normal | |
12 | 21 | Fetal growth retardation, delivery at 26 wk | Died, sepsis |
13 | 22 | Preeclampsia | Normal |
Sixteen pregnancies in women 1 through 10 were previously reported.27 Women 5 and 8 have had an additional normal pregnancy since this previous publication. No women received prophylactic treatments for TTP (eg, rituximab) preceding or during their pregnancies. Women 1, 3, 9, and 13 each had 1 previous pregnancy that was associated with their initial episode of TTP, occurring at 7 weeks’ gestation, the day of delivery, postpartum day 9 and postpartum day 45. Only woman 9 has had relapse episodes of TTP following these pregnancies; she had 2 relapses (not associated with a pregnancy) 25 and 35 months following her normal pregnancy. Woman 12 is currently pregnant, due in September 2018.
NA, child outcome when fetal loss occurred before the gestational age of viability.